Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JTV-519 hemifumarate,Antiarrhythmic and cardioprotective properties. is a Ca2+-dependent blocker of sarcoplasmic reticulum Ca2+-stimulated ATPase (SERCA) and a partial agonist of ryanodine receptors in striated muscle.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | Inquiry | |
50 mg | 6-8 weeks | Inquiry | |
100 mg | 6-8 weeks | Inquiry |
Description | JTV-519 hemifumarate,Antiarrhythmic and cardioprotective properties. is a Ca2+-dependent blocker of sarcoplasmic reticulum Ca2+-stimulated ATPase (SERCA) and a partial agonist of ryanodine receptors in striated muscle. |
In vitro | JTV-519 inhibits inward Ca2+ movement into large unilamellar vesicles (LUV) caused by annexin V in a dose-dependent manner. In the presence of 50 nM annexin V and 400 μM Ca2+, 3 μM JTV-519 shows significant inhibition of Ca2+ movement due to annexin V, and 50% inhibition is achieved at 25 μM K201. |
In vivo | JTV-519 improves cardiac function in CLP mice, where the fractional shortening (FS) and ejection fraction (EF) are significantly increased as compared with CLP mice without JTV-519 treatment. |
Synonyms | K201 hemifumarate |
Molecular Weight | 965.28 |
Formula | C54H68N4O8S2 |
CAS No. | 1435938-25-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JTV-519 hemifumarate 1435938-25-2 PI3K/Akt/mTOR signaling MELK JTV519 K 201 Hemifumarate JTV 519 JTV-519 Hemifumarate JTV-519 K201 JTV 519 hemifumarate JTV519 Hemifumarate JTV519 hemifumarate K201 Hemifumarate K201 hemifumarate K 201 JTV 519 Hemifumarate K-201 Hemifumarate K-201 inhibitor inhibit